![](/img/cover-not-exists.png)
280MO Progression free survival with endocrine therapy, before or after chemotherapy, in patients with hormone receptor-positive/HER2-negative metastatic breast cancer in a large multicenter national observational study
Corbaux, P., Lardy-Cleaud, A., Alexandre, M., Fontanilles, M., Levy, C., Viansone, A.A., Mailliez, A., Debled, M., Gonçalves, A., Le Du, F., Lerebours, F., Ferrero, J-M., Eymard, J-C., Mouret-ReynierVolume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.382
Date:
September, 2020
File:
PDF, 87 KB
2020